Emily Marie Kingston

Ms. Emily Marie Kingston

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
ACAna Cláudia Calchi
Ana Cláudia Calchi
CMCharlotte Moore
Charlotte Moore
LBLillianne Rae Bartone
Lillianne Rae Bartone
EKEmily Marie Kingston
Emily Marie Kingston
MAMarcos André
Marcos André
RMRicardo G Maggi
Ricardo G Maggi
More than one-hundred Babesia species that affect animals and humans have been described, eight of which have been associated with emerging and underdiagnosed zoonoses. Most diagnostic studies in humans have used serology or molecular assays based on the 18S rRNA gene. Because the 18S rRNA gene is highly conserved, obtaining an accurate diagnosis at the species level is difficult, particularly when the amplified DNA fragment is small. Also, due to its low copy number, sequencing of the product is often unsuccessful. In contrast, because the Babesia internal transcribed regions (ITS), between 18S rRNA and 5.8S rRNA, and between 5.8S rRNA and 28S rRNA, contain highly variable non-coding regions, the sequences in these regions provide a good option for developing molecular assays that facilitate differentiation at the species level. In this study, the complete ITS1 and ITS2 intergenic regions of different Piroplasmida species were sequenced to add to the existing GenBank database. Subsequently, ITS1 and ITS2 sequences were used to develop species-specific PCR assays and specific single-plex and multiplex conventional (c)PCR, quantitative real-time (q)PCR, and digital (d)PCR assays for four zoonotic Babesia species (Babesia divergens, Babesia odocoilei, Babesia duncani, and Babesia microti). The efficacy of the assay protocols was confirmed by testing DNA samples extracted from human blood or enrichment blood cultures. Primers were first designed based on the 18S rRNA-5.8S rRNA and 5.8S rRNA-28S rRNA regions to obtain the ITS1 and ITS2 sequences derived from different Piroplasmida species (B. odocoilei, Babesia vulpes, Babesia canis, Babesia vogeli, Babesia gibsoni, Babesia lengau, Babesia divergens-like, B. duncani, B. microti, Babesia capreoli, Babesia negevi, Babesia conradae, Theileria bicornis, and Cytauxzoon felis). Subsequently, using these sequences, single-plex or multiplex protocols were optimized targeting the ITS1 region of B. divergens, B. microti, and B. odocoilei. Each protocol proved to be sensitive and specific for the four targeted Babesia sp., detecting 10−2 (for B. microti and B. odocoilei) and 10−1 (for B. divergens and B. duncani) DNA copies per microliter. There was no cross-amplification among the Babesia species tested. Using 226 DNA extractions from blood or enrichment blood cultures obtained from 82 humans, B. divergens (seven individuals), B. odocoilei (seven individuals), and B. microti (two individuals) were detected and identified as a single infection, whereas co-infection with more than one Babesia sp. was documented by DNA sequencing in six (7.3%) additional individuals (representing a 26.8% overall prevalence). These newly developed protocols proved to be effective in detecting DNA of four Babesia species and facilitated documentation of co-infection with more than one Babesia sp. in the same individual.

23 January 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
RMRicardo G Maggi
Ricardo G Maggi
CMCharlotte Moore
Charlotte Moore
CRCynthia Robveille
Cynthia Robveille
RGRosalie Greenberg
Rosalie Greenberg
EKEmily Marie Kingston
Emily Marie Kingston
This study reinforces the value of a One Health approach to infectious disease outbreak investigations. After the onset of neuropsychiatric symptoms in their son, our investigation focused on a family composed of a mother, father, two daughters, the son, two dogs, and a rabbit, all with exposures to vectors (fleas and ticks), rescued dogs, and other animals. Between 2020 and 2022, all family members experienced illnesses that included neurological symptoms. Prolonged menorrhagia (130d) in the youngest daughter ultimately resolved following antibiotic administration. One dog was diagnosed with a splenic hematoma and months later spinal histiocytic sarcoma. The father, both daughters, and one dog were seroreactive to multiple Bartonella spp. antigens, whereas the mother and son were not seroreactive. Bartonella quintana DNA was amplified from specimens obtained from all family members. Based upon DNA sequencing, infection with B. quintana was confirmed for the mother and both pet dogs. Bartonella henselae DNA was amplified and sequenced from the youngest daughter, the son, and one dog (co-infected with B. quintana), and from Ctenocephalides felis collected from their pet rabbit. All five family members and one dog were infected with Babesia divergens-like MO-1. Both parents were co-infected with Babesia microti. Droplet digital PCR supported potential infection with a Borrelia species in three family members. This study provided additional case-based evidence supporting the role of stealth Babesia, Bartonella, and Borrelia pathogens as a cause or cofactor in neurological and neuropsychiatric symptoms. We conclude that a One Health investigation approach, particularly for stealth vector borne pathogens such as Babesia, Bartonella, and Borrelia spp., will enhance clinical and epidemiological understanding of these organisms for animal and human health. During outbreak investigations it is critical to document travel and vector exposure histories, symptoms, and pathology in pets and human patients, contact with rescued, wild, or feral animals and perform diagnostic testing that includes family members, pets, and vectors.

12 March 2025 in Journal of Central Nervous System Disease
Verified
Journal Article
Open access
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
RMRicardo G. Maggi
Ricardo G. Maggi
CRCynthia Robveille
Cynthia Robveille
EKEmily Marie Kingston
Emily Marie Kingston
Background: In conjunction with more sensitive culture and molecular diagnostic testing modalities, simultaneous or sequential infection with more than 1 vector borne zoonotic pathogen is being increasingly documented in human patients. On a frequent basis, many people are exposed to apparently healthy, but infected, domestic and wild animals, the arthropod vectors with which these animals have co-evolved, and the bacterial, protozoal and other pathogens for which various animals are reservoirs. Unsuspected zoonotic transmission by scratch, bite, or vector exposures can result in chronic, indolent, or potentially life-threatening infections. Methods: In December 2016, at 2 years of age, a male child residing in Ontario, Canada received facial scratches from a feral cat. In August 2018, seizures began 8 days after the child developed a focal, suspected insect bite rash. In June 2019, potential mold toxicity in the child’s bedroom was assessed by fungal culture and urinary mycotoxin assays. Beginning in January 2022, Bartonella spp. serology (indirect fluorescent antibody assays), polymerase chain reaction (PCR) amplification, DNA sequencing, and enrichment blood and brain cultures were used on a research basis to assess Bartonella spp. bloodstream and central nervous system (brain biopsy) infection. In 2024, using recently developed PCR and DNA sequencing targets, Babesia species infection was retrospectively assessed due to the rash observed in 2018. Results: Although there was historical cat and suspected tick exposures, serological testing for Bartonella henselae and Borrelia burgdorferi were repeatedly negative. Sequential neurodiagnostic testing partially supported a diagnosis of Rasmussen’s encephalitis. Astrogliosis was the only brain biopsy histopathological abnormality. Bartonella henselae DNA was amplified and sequenced from enrichment cultures of brain tissue. Retrospectively, Babesia odocoilei and Babesia divergens -like MO-1 infections were confirmed by amplification and sequencing of DNA extracted from enrichment blood cultures processed in January 2022, from blood and brain tissue cultures in June 2022, and blood in January and June 2023. Conclusions: Infection with B . henselae , B . odocoilei , and B . divergens -like MO-1, complicated by mycotoxin exposure, created a complex clinical scenario for this child, his parents, and his doctors.

19 December 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
RMRicardo G Maggi
Ricardo G Maggi
JBJanice C. Bush
Janice C. Bush
EKEmily Marie Kingston
Emily Marie Kingston
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a medical condition characterized by extreme fatigue lasting at least 6 months. Based upon case reports, patients infected with Babesia or Bartonella spp. have reported a history of chronic fatigue and concurrent neurological symptoms. In this study, 50 study participants reporting fatigue lasting from six months to 19 years and one or more neurological symptoms were selected. PCR assays were used to amplify Babesia and Bartonella spp. DNA from blood and enrichment blood cultures. Using targeted qPCR amplification and DNA sequencing, infection with Babesia spp., Bartonella spp. or both genera was confirmed in 10, 11, and 2 individuals, respectively. Of 50 participants, 12 (24%, 95% CI: 12–36%) were infected with a Babesia species, while Bartonella species infection was documented in 13/50 individuals (26%, 95% CI: 13.8–38.2%). This study provides documentation supporting a potential role for Babesia and Bartonella infection in patients with presentations consistent with ME/CFS. Prospective case–control studies, using highly sensitive direct pathogen detection techniques, are needed to determine whether or the extent to which infection with members of these two genera contributes to or causes ME/CFS.

27 July 2026 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
CRCynthia Robveille
Cynthia Robveille
RMRicardo G Maggi
Ricardo G Maggi
HLHenry Hudson Lindner
Henry Hudson Lindner
BHBrent T. Harris
Brent T. Harris
EKEmily Marie Kingston
Emily Marie Kingston
Background: Vector-borne diseases represent an emerging global threat to public health, yet the potential role of flea and tick-borne pathogens as a cause or cofactor in neuropsychiatric illnesses and suicidal ideation remains relatively uninvestigated. Co-infections with vector-borne Babesia and Bartonella spp., as well as infection with more than one Babesia species, may represent a more important cause of neurological and neuropsychiatric illnesses than is currently appreciated. Methods: Postmortem blood, tissue, and urine samples from six chronically ill youths who ended or wanted to end their lives were tested for molecular evidence of Babesia, Bartonella , and Borrelia spp. using qPCR, dPCR, and enrichment blood culture. Results: Infections with Babesia , Bartonella , or both genera were confirmed by DNA sequencing in five of six subjects. Three different Babesia spp. were detected in four subjects, of whom two were infected with more than one Babesia sp. All six had equivocal Bartonella spp. dPCR + or enrichment culture dPCR + results. Bartonella henselae was confirmed by DNA sequencing in two individuals. Borrelia dPCR was equivocally positive in one subject but could not be confirmed by DNA sequencing. Conclusions: These findings support the hypothesis that persistent Bartonella and Babesia spp. infections may have a causal role in chronic illness and potentially suicidality in young people. More research is needed to determine the prevalence and role of these pathogens in patients with chronic physical and neuropsychiatric symptoms and suicidal ideation.

30 October 2026 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Open access
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
RMRicardo G Maggi
Ricardo G Maggi
DKDavid Kaufman
David Kaufman
JDJaidyn Dillon-McBride
Jaidyn Dillon-McBride
EKEmily Marie Kingston
Emily Marie Kingston
This study investigated the presence of Babesia , Bartonella , and Borrelia spp infection in an extended veterinary family. Between May 2023 and August 2025, 8 individuals enrolled in an Institutional Review Board–approved observational study. Serological evidence of Bartonella spp exposure and molecular evidence of Babesia , Bartonella , and Borrelia spp infection were assessed. Among other symptoms, at least half of the study participants reported chronic fatigue, headaches, anxiety, depression, and difficulty remembering. On the basis of PCR amplification and DNA sequencing, infection with Babesia odocoilei , Babesia divergens –like MO-1, Babesia gibsoni , or Babesia microti was confirmed in 4 individuals . Three other individuals were PCR positive for Piroplasmida/Apicomplexa DNA. Four individuals were seroreactive to 1 or more Bartonella spp and 6 individuals were Bartonella PCR positive in blood, serum, or enrichment blood cultures. Six individuals had at least 1 Borrelia partition detected by digital PCR; however, efforts in our laboratory to confirm Borrelia digital PCR positivity by DNA sequencing were not successful. Similar to this extended veterinary family, previous studies have documented that veterinarians and veterinary workers may be occupationally at risk for exposure to Bartonella spp. On the basis of the results of this study, veterinary workers may also be at risk for infection with Babesia spp and potentially other Piroplasmida/Apicomplexa organisms. The potential that chronic intravascular or endotheliotropic infections with vector-borne pathogens contributes to multisystem illnesses in veterinary workers deserves future research considerations, which, on a clinical, epidemiological, and microbiological basis, will require sequential lifetime studies.